Centenary is at the heart of Sydney’s new five-year plan for clinical research just launched by the NSW Minister for Health and Medical Research, Jillian Skinner.
“We applaud the SLHD for having the foresight to have a strategic approach to medical research, and look forward to an ever closer collaboration that will enrich our patients’ lives,” said Centenary’s Executive Director, Professor Mathew Vadas, AO.
The launch itself demonstrated the Institute’s pivotal role, because it also served as the opening for Royal Prince Alfred Hospital’s new Cell and Molecular Therapies Laboratories which will be run by Centenary’s head of Gene and Stem Cell Therapy, Professor John Rasko AO.
“With this milestone we open up new opportunities for treating patients who suffer from cancer, genetic and other diseases,” Professor Rasko says.
Speaking at the opening Mrs Skinner agreed. “The hospital’s new state-of-the-art cell and molecular therapies labs form an important part of the five-year medical research road map and will demonstrate firsthand the great things that can happen when research is intertwined with clinical practice,” she said.
“Sydney Local Health District (LHD), through its strong links to the Universities and partnerships with research institutes, has a long history of investing in research which makes a direct impact at the bedside.”
Announcing the appointment of Professor Warwick Britton as the first Director of Research for Sydney LHD, Chief Executive, Dr Teresa Anderson said “We will continue to value our researchers and we will support their endeavours to take their work from bench to bedside, improving patient outcomes and changing lives for the better.” Dr Teresa Anderson is also a member of Centenary Institute’s Board of Governors.